Secondary osteoporosis: Are we recognizing it?

Journal of Women's Health

Volumn 15, Issue 10, 2006, Pages 1174-1183

  Sikon, Andrea L ^a   Thacker, Holly L ^a   Carey, John ^a   Deal, Chad ^a   Licata, Angelo A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HEALTH CARE DELIVERY; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; POPULATION RESEARCH; PRIMARY HYPERPARATHYROIDISM; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SECONDARY OSTEOPOROSIS; VITAMIN D DEFICIENCY;

AGED; BONE DENSITY; DENSITOMETRY, X-RAY; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; PREVENTIVE MEDICINE; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION; RISK ASSESSMENT; UNITED STATES; WOMEN'S HEALTH; WOMEN'S HEALTH SERVICES;

EID: 33846557997     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2006.15.1174     Document Type: Article

References (37)

1. Bone health and osteoporosis: A Report of the Surgeon General. Executive Summary. U.S. Department of Health and Human Services, 2004;I:viii.
2. National Osteoporosis Foundation. America's bone health: The state of osteoporosis and low bone mass. Available at www.nof.org/advocacy/ prevalence Accessed May 13, 2006.
3. Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: Results from the National Osteoporosis Risk Assessment. JAMA 2001;286:2815.
4. Stafford R, Drieline R, Hersh A. National trends in osteoporosis visits and osteoporosis treatment, 1988-2003. Arch Intern Med 2004;164:1525.
5. Chapuy MC, Chapuy P, Meunier PJ. Calcium and vitamin D supplements: Effects on calcium metabolism in elderly people. Am J of Clin Nutr 1987;46:324.
6. Silverberg SJ, Bilezikian JP. "Incipient" primary hyperparathyroidism: A "forme fruste" of an old disease. J Clin Endocrinol Metab 2003;8:5348.
7. Lips P, Duong T, Oleksik A, et al. A global study of vitamin D status and parathyroid function In post-menopausal women with osteoporosis: Baseline data from the Multiple Outcomes of Raloxifene Evaluation Clinical Trial. J Clin Endocrin Metab 2001;86:1212.
8. Malabanan A, Veronikis I, Holick M. Redefining vitamin D insufficiency. Lancet 1998;351:805.
9. NIH Consensus Development Conference: Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785.
10. Fitzpatrick LA. Secondary causes of osteoporosis. Mayo Clin Proc 2002;77:453.
11. Leib E, Lewiecki M, Binkley N, Hamdy R. Official positions of the International Society of Clinical Densitometry. www.iscd.org/Visitors/ pdfs/ISCD_OP2005_000.pdf Accessed May 13, 2006.
12. Hollis B. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D. 2005;135:317.
13. Calvo MS, Whiting SJ, Barton CN. Vitamin D fortification in the United States and Canada: Current status and data needs. Am J Clin Nutr 2004;80(Suppl):1710S.
14. 2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004; 89:5387.
15. Heaney RP. The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 2005;97:13.
16. Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int 2005;16:713.
17. Lips P. Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 2004; 89-90:611.
18. Holick M, Siris E, Binkley N, Beard M, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005;90:3215.
19. Gordon C, DePeter K, Feldman H, et al. Prevalence of Vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 2004;158:531.
20. 3 and calcium to prevent hip fractures in the elderly woman. N Engl J Med 1992; 327:1637.
21. Dawson-Hughes B, Harris SS, Krall EA, et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670.
22. Dawson-Hughes B, Dallai GE, Krall EA, et al. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990;323:878.
23. Reid IR, Ames RW, Evans MC, et al. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: A randomized controlled trial. Am J Med 1995;98:331.
24. Recker RR, Hinders S, Davies KM, et al. Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res 1996;11: 1961.
25. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials. JAMA 2005;293:2257.
26. Jackson RD, LaCroix AZ, Gass M, et al. Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669.
27. Dhesi J, Jackson K, Stephen HD, et al. Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing 2004;33:589.
28. The prevention of falls in later life. A report of the Kellogg International Work Group on the Prevention of Falls by the Elderly. Dan Med Bull 1987;34 (Suppl 4):1.
29. Prabhala A, Garg R, Dandona P. Severe myopathy associated with vitamin D deficiency in western New York. Arch Intern Med 2000;160:1199.
30. Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged ≥ 60 years. Am J Clin Nutr 2004;80:752.
31. Bischoff-Ferrari H, Dawson-Hughes B, Willett W, et al. Effect of vitamin D on falls: A meta-analysis. JAMA 2004;291:1999.
32. Venning G. Recent developments in vitamin D deficiency and muscle weakness among elderly people. BMJ 2005;330:524.
33. de Moraes-Ruehsen M, Jones GS. Premature ovarian failure. Fertil Steril 1967;18:440.
34. Bilezikian JP, Potts JT Jr, Fuleihan Gel-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: A perspective for the 21st century. J Bone Miner Res 2002;17:(Suppl 2):N2.
35. Bilezikian JP, Silverberg SJ. Clinical practice. Asymptomatic primary hyperparathyroidism. N Engl J Med 2004;350:1746.
36. Khosla S, Atkinson EJ, Melton LJ, Riggs BL. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: A population-based study. J Clin Endocrinol Metab 1997;82:1522.
37. Marx, SJ. Primer on metabolic bone diseases and disorders of mineral metabolism, 5th ed. Chapter 35, pgs. 239-242. The American Society of Bone and Mineral Research, Washington, DC.